Epidural dexmedetomidine infusion in a patient with chronic opioid use and intractable pain following abdominoperineal resection

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Dexmedetomidine is a selective alpha 2 adrenergic agonist with known analgesic properties. Its perioperative use is associated with reduced pain scores and an opioid sparing effect. Management of postoperative pain in patients with a history of chronic opioid use can be challenging. Multimodal analgesia is recommended although the perioperative use of dexmedetomidine has not been extensively studied in this patient population. We present a case of intractable abdominal pain following open abdominoperineal resection in a patient with rectal cancer and a history of chronic opioid use. Following the introduction of dexmedetomidine into the patient's postoperative epidural solution, a noticeable decline in reported pain scores and use of breakthrough analgesia was appreciated. The analgesic efficacy of epidural dexmedetomidine in patients with a history of chronic opioid use warrants further study.

Cite

CITATION STYLE

APA

Silvaggio, M. P., Toman, M. K., & Peters, B. (2020). Epidural dexmedetomidine infusion in a patient with chronic opioid use and intractable pain following abdominoperineal resection. Oxford Medical Case Reports, 2020(4), 1–4. https://doi.org/10.1093/omcr/omaa021

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free